SelectQuote Q1 revenue slightly beats estimates on higher pharmacy sales
SLQT•SelectQuote’s fiscal first-quarter revenue fell 15% to $280 million but slightly beat the $277.91 million analyst estimate. The company forecast fiscal 2027 revenue of $1.35 billion to $1.45 billion and adjusted EBITDA of $90 million to $115 million.
1. Quarterly results
SelectQuote reported fiscal first-quarter revenue of $280 million, slightly above the $277.91 million consensus estimate, while revenue fell 15% year over year. Net loss was $20.30 million, and adjusted EBITDA loss was $17 million, narrower year over year.
2. Outlook and drivers
The company expects fiscal 2027 revenue of $1.35 billion to $1.45 billion, adjusted EBITDA of $90 million to $115 million, and operating cash flow above $60 million. SelectQuote attributed improved adjusted EBITDA to operational efficiencies, including lower agent headcount in Senior and scaling Healthcare Services. It said profitability per SelectRx member rose 60% and cited higher pharmacy revenue for an increase in per-policy revenue.
